Online
|
|
BSE Announcements on Plethico Pharma
Posted by :
MMB Messenger
Plethico Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on March 31, 2009, inter alia, to consider the following:
1. Approve and take on record the Quarterly / Yearly Audited Financial Results of the Company for the quarter / year ended on December 31, 2008; and
2. Recommendation of dividend for the year ending December 31, 2008, if any....
Board to consider dividend
Posted by : vkk43
Plethico Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on March 31, 2009, inter alia, to consider the following:
1. Approve and take on record the Quarterly / Yearly Audited Financial Results of the Company for the quarter / year ended on December 31, 2008; and
2. Recommendation of dividend for the year ending December 31, 2008, if any....
EGM on 31st March
Posted by : vkk43Plethico Pharmaceuticals Ltd has informed BSE that an Extra Ordinary General Meeting (EGM) of the Company will be held on March 31, 2009....
BSE Announcements on Plethico Pharma
Posted by : MMB MessengerPlethico Pharmaceuticals Ltd has informed BSE that an Extra Ordinary General Meeting (EGM) of the Company will be held on March 31, 2009....
Outcome of board meeting
Posted by : vkk43
Plethico Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on March 09, 2009, inter alia, has decided the following:
1. To borrow, subject to the approval of the Company in general meeting, to the extent of Rs 1200 crores, notwithstanding that the moneys to be borrowed together with the moneys already borrowed by the Company (apart from temporary loans, if any, obtained from the Company`s bankers in the ordinary course of business) will exceed the aggregate of the paid-up capital of the Company and its free reserves.
2. To consider, subject to the approval of the company in general meeting, the issuance of equity shares and / or foreign currency convertible bonds ("FCCBs") and / or global depository receipts and / or other securities convertible into equity shares and / or such other equity-linked instruments to an extent of US $ 40 Million Indian Rupee equivalent, including but not limited to, by way of a qualified institutional placement.
3. To look into and evaluate options for managing the liabilities of the Company through various initiatives, such as amending the terms and conditions of the outstanding FCCBs issued by the Company, including, but not limited to, tenor, interest rate, yield to maturity, etc. as well as other methods of extinguishing or restructuring the FCCBs, including but not limited to buy-back / early redemption of the FCCBs, as may be permitted by applicable law.
The Company has appointed Jefferies International Ltd to advise the Company in relation to the above.
The decisions of the board at serial nos. 1 and 2 above are subject, inter alia, to the approval by the shareholders of the Company and the Company will, in this regard, calling an extra ordinary general meeting of all its shareholders.
The Extra-ordinary General Meeting of the Company is proposed to be held on March 31, 2009....
NSE Announcements on Plethico Pharma
Posted by : MMB MessengerPlethico Pharmaceuticals Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on March 09, 2009 decided the following: [1] To borrow, subject to the approval of the Company in general meeting, to the extent of Rs.1200 crores, notwithstanding that the moneys to be borrowed together with the moneys already borrowed by the Company (apart from temporary loans, if any, obtained from the Companys bankers in the ordinary course of business) will exceed the aggregate of the paid-up capital of the Company and its free reserves; [2] To consider, subject to the approval of the company in general meeting the issuance of equity shares and/or foreign currency convertible bonds ("FCCBs") and/or global depository receipts and/or other securities convertible into equity shares and/or such other equity-linked instruments to an extent of US$40 Million Indian Rupee equivalent, including, but not limited to, by way of a qualified institutional placement; [3] To look into and evaluate options for managing the liabilities of the Company through various initiatives, such as amending the terms and conditions of the outstanding FCCBS issued by the Company, including, but not limited to, tenor, interest rate, yield to maturity, etc., as well as other methods of extinguishing or restructuring the FCCBs, including but not limited to, buy- back/ early redemption of the FCCBs, as may be permitted by applicable law. The Company has appointed Jefferies International Limited to advise the Company in relation to the above. The decisions of the board at serial nos. 1 and 2 above are subject, inter alia, to the approval by the shareholders of the Company and the Company will, in this regard, calling an extraordinary general meeting of all its shareholders. The Extra-ordinary General Meeting of the Company is proposed to be held on March 31, 2009....
BSE Announcements on Plethico Pharma
Posted by : MMB Messenger
Plethico Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on March 09, 2009, inter alia, has decided the following:
1. To borrow, subject to the approval of the Company in general meeting, to the extent of Rs 1200 crores, notwithstanding that the moneys to be borrowed together with the moneys already borrowed by the Company (apart from temporary loans, if any, obtained from the Companys bankers in the ordinary course of business) will exceed the aggregate of the paid-up capital of the Company and its free reserves.
2. To consider, subject to the approval of the company in general meeting, the issuance of equity shares and / or foreign currency convertible bonds ("FCCBs") and / or global depository receipts and / or other securities convertible into equity shares and / or such other equity-linked instruments to an extent of US $ 40 Million Indian Rupee equivalent, including but not limited to, by way of a qualified institutional placement.
3. To look into and evaluate options for managing the liabilities of the Company through various initiatives, such as amending the terms and conditions of the outstanding FCCBs issued by the Company, including, but not limited to, tenor, interest rate, yield to maturity, etc. as well as other methods of extinguishing or restructuring the FCCBs, including but not limited to buy-back / early redemption of the FCCBs, as may be permitted by applicable law.
The Company has appointed Jefferies International Ltd to advise the Company in relation to the above.
The decisions of the board at serial nos. 1 and 2 above are subject, inter alia, to the approval by the shareholders of the Company and the Company will, in this regard, calling an extra ordinary general meeting of all its shareholders.
The Extra-ordinary General Meeting of the Company is proposed to be held on March 31, 2009....
Top exporter award for the year 2007-08
Posted by : vkk43
Plethico Pharmaceuticals Ltd has informed BSE that the manufacturing unit of the Company situated at Kandla Special Economic Zone has been awarded with the "Top Exporter Award" for the year 2007-08 for combined category of manufactured products & services by the Office of Development Commissioner, Kandla Special Economic Zone, Ministry of Commerce and Industry.
Plethico Pharmaceuticals Ltd has won this award consecutively for the second time. Earlier also Company had won awarded the Top Exporter Award for the year 2003-04. ...
NSE Announcements on Plethico Pharma
Posted by : MMB MessengerPlethico Pharmaceuticals Limited has informed the Exchange that: "The manufacturing unit of the Company situated at Kandla Special Economic Zone has been awarded with the "Top Exporter Award" for the year 2007-08 for combined category of manufactured products & services by the Office of Development Commissioner, Kandla Special Economic Zone, Ministry of Commerce and Industry. Plethico Pharmaceuticals Limited has won this award consecutively for the second time. Earlier also Company had won awarded the Top Exporter Award for the year 2003-04."...
BSE Announcements on Plethico Pharma
Posted by : MMB Messenger
Plethico Pharmaceuticals Ltd has informed BSE that the manufacturing unit of the Company situated at Kandla Special Economic Zone has been awarded with the "Top Exporter Award" for the year 2007-08 for combined category of manufactured products & services by the Office of Development Commissioner, Kandla Special Economic Zone, Ministry of Commerce and Industry.
Plethico Pharmaceuticals Ltd has won this award consecutively for the second time. Earlier also Company had won awarded the Top Exporter Award for the year 2003-04....
BSE Announcements on Plethico Pharma
Posted by : MMB MessengerPlethico Pharmaceuticals Ltd has informed BSE that Natrol Global FZ LLC, manufacturers of herbal products, shall base their regional headquarters at DuBiotech to cater to the increasing demand for nutritional supplements in the Middle East and Africa regions....
NSE Announcements on Plethico Pharma
Posted by : MMB MessengerPlethico Pharmaceuticals Limited has informed the Exchange that Natrol Global FZ LLC, manufacturers of herbal products, shall base their regional headquarters at DuBiotech to cater to the increasing demand for nutritional supplements in the Middle East and Africa regions. Natrol Global is a sister company of Natrol Inc, US, and a subsidiary of Plethico Pharmaceuticals Ltd. a herbal/nutraceutical focus company that engages in the manufacturing, marketing and distribution of pharmaceutical and allied healthcare products. Nutraceuticals are health food supplements that include products such as functional foods, vitamins, minerals, amino acids, sports nutrition, energy and wellness drinks.The details of the same shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements) ...
Plethico Pharmaceuticals’ 100% book-built IPO
Posted by :
suresh_esg
There are plenty of stocks now to choose. As the overall sentiment is down, most of the stocks are available at a very cheap valuations.
However, there is no surity that these stocks do not dip further!!!!...
Plethico Pharmaceuticals’ 100% book-built IPO
Posted by : readarticle
This stock has been beaten down badly. Not sure why?
But looking at fundas it seems like it will rock and might reach 1500 levels....
Plethico Pharmaceuticals’ 100% book-built IPO
Posted by :
gunnuuplethico pharma is a wonderful buy,it is trading at half of book value which is nearly 200/- and 1000 crores turnover and profits around 130 crores per year and eps is at arund 40/-,it is an exellent buy for medium and long term players and going to be a multi bagger stock...
